<!DOCTYPE html>
<html class="theme-sleek astro-STCLZLJ5" lang="en">
  <head>
    <!-- Global Metadata -->
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width,initial-scale=1">
    <meta name="theme-color" media="(prefers-color-scheme: light)" content="#ffffff">
<meta name="theme-color" media="(prefers-color-scheme: dark)" content="#18181b">
<!-- 
  This is an example. 
  Use https://realfavicongenerator.net to generate the icons and manifest. 
-->
<link href="/favicon.ico" rel="shortcut icon">

    <!-- Primary Meta Tags --><title>A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment.</title>
<meta name="title" content="A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment.">
<meta name="description" content="Medical Cannabis Awareness New Zealand">


<!-- Open Graph / Facebook -->
<meta property="og:title" content="A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment.">
<meta property="og:description" content="Medical Cannabis Awareness New Zealand">
<meta property="og:type" content="article">
<meta property="og:url" content="https://mcanz.org.nz/blog/2179-2">

<meta property="article:published_time" content="2016-01-06T00:00:00.000Z">





<!-- Twitter -->
<meta property="twitter:title" content="A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment.">
<meta property="twitter:description" content="Medical Cannabis Awareness New Zealand">


<meta property="twitter:card" content="summary_large_image">


<!-- {twitter.url && <meta property="twitter:url" content={twitter.url} />} -->

  <link rel="stylesheet" href="/assets/_slug_.2607fc28.css" />
<link rel="stylesheet" href="/assets/_slug_.f022e152.css" /></head>

  <body class="text-text-body bg-bg-body max-w-3xl mx-auto px-4 sm:px-8 astro-STCLZLJ5">
    <header class="astro-FAM4J5CX">
  <a class="skip-to-main astro-FAM4J5CX" href="#main"> Skip to content</a>
  <nav class="astro-FAM4J5CX">
    <section class="astro-FAM4J5CX">
      <ul class="astro-FAM4J5CX">
        <li class="astro-FAM4J5CX"><!-- DO NOT FORMAT. IT ADDS AN EXTRA SPACE ON RENDERED CONTENT. --><a href="/" class="astro-FAM4J5CX header-link unset animated gradient-colors astro-C675TBRQ">Home</a>
</li>
        <li class="astro-FAM4J5CX"><!-- DO NOT FORMAT. IT ADDS AN EXTRA SPACE ON RENDERED CONTENT. --><a href="/blog" class="astro-FAM4J5CX active header-link unset animated gradient-colors astro-C675TBRQ">Blog</a>
</li>
      </ul>
    </section>
  </nav>
</header>

    <main id="main" class="astro-STCLZLJ5">
      <section class="blog-post astro-STCLZLJ5">
        <h1 class="title astro-STCLZLJ5">A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment.</h1>
        <time class="publish-date astro-STCLZLJ5">Jan 6, 2016</time>
        <article><p>Authors <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Serpell%20M%5BAuthor%5D&#38;cauthor=true&#38;cauthor_uid=24420962">Serpell M</a>1, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ratcliffe%20S%5BAuthor%5D&#38;cauthor=true&#38;cauthor_uid=24420962">Ratcliffe S</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Hovorka%20J%5BAuthor%5D&#38;cauthor=true&#38;cauthor_uid=24420962">Hovorka J</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Schofield%20M%5BAuthor%5D&#38;cauthor=true&#38;cauthor_uid=24420962">Schofield M</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Taylor%20L%5BAuthor%5D&#38;cauthor=true&#38;cauthor_uid=24420962">Taylor L</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lauder%20H%5BAuthor%5D&#38;cauthor=true&#38;cauthor_uid=24420962">Lauder H</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ehler%20E%5BAuthor%5D&#38;cauthor=true&#38;cauthor_uid=24420962">Ehler E</a>.</p><h3>Abstract</h3><h4>Background</h4><p>Peripheral neuropathic pain (PNP) associated with allodynia poses a significant clinical challenge. The efficacy of Δ9-tetrahydrocannabinol/cannabidiol (THC/CBD) oromucosal spray, a novel cannabinoid formulation, was investigated in this 15-week randomized, double-blind, placebo-controlled parallel group study.</p><h4>Methods</h4><p>In total, 303 patients with PNP associated with allodynia were screened; 128 were randomized to THC/CBD spray and 118 to placebo, in addition to their current analgesic therapy. The co-primary efficacy endpoints were the 30% responder rate in PNP 0–10 numerical rating scale (NRS) score and the mean change from baseline to the end of treatment in this score. Various key secondary measures of pain and functioning were also investigated.</p><h4>Results</h4><p>At the 30% responder level, there were statistically significant treatment differences in favour of THC/CBD spray in the full analysis (intention-to-treat) dataset [<em>p</em> = 0.034; 95% confidence interval (CI): 1.05–3.70]. There was also a reduction in mean PNP 0–10 NRS scores in both treatment groups that was numerically higher in the THC/CBD spray group, but which failed to reach statistical significance. Secondary measures of sleep quality 0–10 NRS score (<em>p</em> = 0.0072) and Subject Global Impression of Change (SGIC) (<em>p</em> = 0.023) also demonstrated statistically significant treatment differences in favour of THC/CBD spray treatment.</p><h4>Conclusions</h4><p>These findings demonstrate that, in a meaningful proportion of otherwise treatment-resistant patients, clinically important improvements in pain, sleep quality and SGIC of the severity of their condition are obtained with THC/CBD spray. THC/CBD spray was well tolerated and no new safety concerns were identified.</p><p>Article found on <a href="http://www.ncbi.nlm.nih.gov/pubmed/24420962">Pubmed</a> and availble for <a href="http://onlinelibrary.wiley.com/doi/10.1002/j.1532-2149.2013.00445.x/abstract;jsessionid=2550D9EB9B023CA317E4B9ACA727005C.f01t01">purchase here.</a></p></article>
      </section>
    </main>
    <footer class="astro-5AYKG27L">
  <div class="astro-5AYKG27L">

  </div>
</footer>


  
</body>


</html>